Alzheimer's peptide and serine proteinase inhibitors in glaucoma and exfoliation syndrome (Q44434226)

2 December 2017

Alzheimer's peptide and serine proteinase inhibitors in glaucoma and exfoliation syndrome (English)

1 reference

2 December 2017

0 references

1 reference

10.1023/A:1022949121078

https://api.crossref.org/works/10.1023/A:1022949121078

31 December 2023

1

Sabina Janciauskiene

1 reference

2 December 2017

Torsten Krakau

2

1 reference

2 December 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12737497

31 December 2023

publication date

1 May 2003

1 reference

Documenta Ophthalmologica

2 December 2017

1 reference

2 December 2017

106

1 reference

2 December 2017

3

1 reference

2 December 2017

215-223

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1022949121078

2 December 2017

0 references

cites work

[Pathogenesis of the pseudoexfoliation syndrome]

1 reference

12 December 2020

A specific structural interaction of Alzheimer's peptide A beta 1-42 with alpha 1-antichymotrypsin.

1 reference

12 December 2020

Ocular hypertension in primary glaucoma: a new hypothesis

1 reference

12 December 2020

Increased growth factor activity in the aqueous humour of patients with exfoliation syndrome

1 reference

12 December 2020

Exfoliation syndrome and occludable angles

1 reference

12 December 2020

Functional damage at diagnosis of primary open angle glaucoma

1 reference

12 December 2020

Molecular and cellular mediators of Alzheimer's disease inflammation

1 reference

12 December 2020

?1-Antichymotrypsin Binding to Alzheimer A? Peptides Is Sequence Specific and Induces Fibril Disaggregation In Vitro

1 reference

12 December 2020

Endogenous proteins controlling amyloid beta-peptide polymerization. Possible implications for beta-amyloid formation in the central nervous system and in peripheral tissues

1 reference

12 December 2020

Studies on the in vitro assembly of a beta 1-40: implications for the search for a beta fibril formation inhibitors

1 reference

12 December 2020

Immunoreactivity against tau, amyloid precursor protein, and beta-amyloid in the human retina

1 reference

12 December 2020

Fluorescein angiography and fluorophotometry of the iris in pseudoexfoliation of the lens capsule

1 reference

12 December 2020

Alzheimer's peptide Abeta1-42 binds to two beta-sheets of alpha1-antichymotrypsin and transforms it from inhibitor to substrate.

1 reference

12 December 2020

Determinants of neuronal vulnerability in neurodegenerative diseases.

1 reference

12 December 2020

Oxidative stress increases production of beta-amyloid precursor protein and beta-amyloid (Abeta) in mammalian lenses, and Abeta has toxic effects on lens epithelial cells.

1 reference

12 December 2020

Traumatic brain injury elevates the Alzheimer's amyloid peptide A beta 42 in human CSF. A possible role for nerve cell injury.

1 reference

12 December 2020

Exfoliation syndrome and exfoliation glaucoma

1 reference

12 December 2020

Inflammation, antichymotrypsin, and lipid metabolism: autogenic etiology of Alzheimer's disease

1 reference

12 December 2020

Dementia with beta-amyloid deposition: involvement of alpha B-crystallin supports two main diseases.

1 reference

12 December 2020

New quantitative method to determine protein concentration and cell number in aqueous in vivo

1 reference

12 December 2020

Amyloid-beta peptides are cytotoxic to oligodendrocytes.

1 reference

12 December 2020

TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes

1 reference

12 December 2020

Vascular aspects in the pathophysiology of glaucomatous optic neuropathy.

1 reference

12 December 2020

Human plasma proteinase inhibitors

1 reference

12 December 2020

Beta-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology

1 reference

12 December 2020

Electrophoretic study of proteins associated with pseudo-exfoliation syndrome

1 reference

12 December 2020

Alpha-1-antichymotrypsin promotes beta-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease.

1 reference

12 December 2020

Pseudo-exfoliation material--an amyloid-like substance

1 reference

12 December 2020

Pseudoexfoliation syndrome for the comprehensive ophthalmologist. Intraocular and systemic manifestations

1 reference

12 December 2020

The exfoliation syndrome in cognitive impairment of cerebrovascular or Alzheimer's type.

1 reference

12 December 2020

Molecular pathogenesis of apolipoprotein E-mediated amyloidosis in late-onset Alzheimer's disease

1 reference

12 December 2020

Approaches to discovery and characterization of inhibitors of amyloid beta-peptide polymerization

1 reference

12 December 2020

Presenilin expression in the ocular lens.

1 reference

12 December 2020

[Cataract and the exfoliative syndrome]

1 reference

12 December 2020

Focal inflammation in the brain: role in Alzheimer's disease

1 reference

12 December 2020

Prion protein expression in mammalian lenses.

1 reference

12 December 2020

Hepatocyte growth factor is increased in the aqueous humor of glaucomatous eyes

1 reference

12 December 2020

1 reference

12 December 2020

The role of the acute-phase protein alpha 1-antichymotrypsin in brain dysfunction and injury

1 reference

12 December 2020

Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity

1 reference

12 December 2020

Is pseudoexfoliation syndrome inherited? A review of genetic and nongenetic factors and a new observation

1 reference

12 December 2020

Amyloid-beta peptide induced inflammatory reaction is mediated by the cytokines tumor necrosis factor and interleukin-1.

1 reference

12 December 2020

Reference distributions for the positive acute phase serum proteins, alpha1-acid glycoprotein (orosomucoid), alpha1-antitrypsin, and haptoglobin: a practical, simple, and clinically relevant approach in a large cohort.

1 reference

12 December 2020

Nerve growth factor modulates the expression and secretion of beta-amyloid precursor protein through different mechanisms in PC12 cells

1 reference

12 December 2020

Inactive conformation of the serpin alpha(1)-antichymotrypsin indicates two-stage insertion of the reactive loop: implications for inhibitory function and conformational disease

1 reference

12 December 2020

The blood-aqueous barrier in eyes with pseudoexfoliation syndrome

1 reference

12 December 2020

Monomeric and polymeric forms of alpha-1 antichymotrypsin in sera from patients with probable late onset Alzheimer's disease

1 reference

12 December 2020

Domains of laminin with growth-factor activity

1 reference

12 December 2020

Induction of the alpha(1)-antichymotrypsin gene in the brain associated with TGF-beta1 deficiency or systemic administration of endotoxin.

1 reference

12 December 2020

The cellular mechanism underlying neuronal degeneration in glaucoma: parallels with Alzheimer's disease

1 reference

12 December 2020

Cataract, Alzheimer's disease, and other conformational diseases.

1 reference

12 December 2020

Alzheimer disease (AD), modified proteins, and aspirin.

1 reference

12 December 2020

Early changes in iris blood vessels in exfoliation syndrome

1 reference

12 December 2020

Local control of alpha1-proteinase inhibitor levels: regulation of alpha1-proteinase inhibitor in the human cornea by growth factors and cytokines

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1022949121078

1 reference

Dimensions Publication ID

2 December 2017

0 references

1 reference